Odroa
A software publisher specializing in the health sector based in Nantes.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
€720k | Seed | ||
| Total Funding | 000k | ||
| USD | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Odroa, established in France on January 14, 2016, operated as a developer of a data management platform specifically tailored for the health-tech sector. The company focused on securing and streamlining medical biology analysis for clients such as hospitals.
The core of Odroa's offering was an artificial intelligence-based platform designed to function without a human-machine interface. This enabled the automation of various customer file management tasks, including collections, shipments, alerts, and report editing. The system was built to handle these processes securely and in compliance with regulations, aiming to save time for medical facilities. The business operated within the artificial intelligence, big data, and HealthTech verticals.
Financially, the company received a grant of $57,100 on November 29, 2021, at which point it was generating revenue. However, according to a filing on February 7, 2024, Odroa entered into bankruptcy and liquidation proceedings, and its website is no longer active, indicating it has ceased operations.
Keywords: data management platform, medical biology analysis, health-tech, artificial intelligence, hospital automation, customer file management, secure data processing, medical compliance, big data analytics, HealthTech solutions, clinical data automation, Odroa, medical software, healthcare administration, AI in healthcare, patient data management, laboratory information system, medical report automation, healthcare workflow, clinical process automation